GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | 8/10/2026 7:33:44 AM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $472,113,000 | EPS -$0.76 | ||
| Jade Biosciences, Inc. (JBIO) | 8/10/2026 7:15:21 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $472,113,000 | EPS -$0.76 | Export Earnings Model | ||
| Jade Biosciences, Inc. (JBIO) | 5/7/2026 4:40:20 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $319,433,000 | EPS -$0.57 | ||
| Jade Biosciences, Inc. (JBIO) | 5/7/2026 4:19:51 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $319,433,000 | EPS -$0.57 | Export Earnings Model | ||
| Jade Biosciences, Inc. (JBIO) | 4/28/2026 4:53:39 PM | View | Proxy | SEC | Y 2025 | ||||||
| Jade Biosciences, Inc. (JBIO) | 3/6/2026 4:24:31 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $349,781,000 | EPS -$3.19 | ||
| Jade Biosciences, Inc. (JBIO) | 3/6/2026 7:12:36 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $349,781,000 | EPS -$0.11 | Export Earnings Model | ||
| Jade Biosciences, Inc. (JBIO) | 11/14/2025 7:23:14 AM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $202,450,000 | EPS -$0.48 | ||
| Jade Biosciences, Inc. (JBIO) | 11/14/2025 7:01:43 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $202,450,000 | EPS -$0.48 | Export Earnings Model | ||
| Jade Biosciences, Inc. (JBIO) | 8/13/2025 4:34:50 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $223,968,000 | EPS -$0.86 | ||
| Jade Biosciences, Inc. (JBIO) | 8/13/2025 4:17:21 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $223,968,000 | EPS -$0.86 | Export Earnings Model | ||
| Jade Biosciences, Inc. (JBIO) | 5/14/2025 4:16:08 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $77,533,000 | EPS -$0.09 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 4/25/2025 4:43:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $77,533,000 | EPS -$0.09 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 3/27/2025 7:42:37 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $80,332,000 | EPS -$2.44 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/12/2024 4:50:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $90,959,000 | EPS -$0.56 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 8/12/2024 4:46:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $111,694,000 | EPS -$0.86 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 5/13/2024 5:09:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $106,821,000 | EPS -$0.83 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 5/13/2024 4:40:48 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $106,821,000 | EPS -$0.83 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 4/26/2024 7:19:10 AM | View | Proxy | SEC | Y 2023 | ||||||
| Aerovate Therapeutics, Inc. (JBIO) | 3/25/2024 4:25:26 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $127,418,000 | EPS -$2.87 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 3/25/2024 4:13:46 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $127,418,000 | EPS -$0.74 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/13/2023 8:45:18 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $140,876,000 | EPS -$0.71 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/13/2023 8:15:20 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $140,876,000 | EPS -$0.71 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 8/14/2023 8:25:59 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $155,755,000 | EPS -$0.76 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 8/14/2023 8:11:33 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $155,755,000 | EPS -$0.76 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 5/15/2023 4:24:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $124,393,000 | EPS -$0.67 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 5/15/2023 4:12:15 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $124,393,000 | EPS -$0.67 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 4/19/2023 4:32:26 PM | View | Proxy | SEC | Y 2022 | ||||||
| Aerovate Therapeutics, Inc. (JBIO) | 3/29/2023 5:20:08 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $135,301,000 | EPS -$2.10 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 3/29/2023 4:54:20 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $135,301,000 | EPS -$0.61 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/14/2022 8:07:55 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $147,656,000 | EPS -$0.56 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/14/2022 7:47:12 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $147,656,000 | EPS -$0.56 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 8/15/2022 8:20:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $155,684,000 | EPS -$0.49 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 8/15/2022 7:56:44 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $155,684,000 | EPS -$0.49 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 5/16/2022 8:17:14 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $166,999,000 | EPS -$0.45 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 5/16/2022 8:01:34 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $166,999,000 | EPS -$0.45 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 4/29/2022 4:57:41 PM | View | Proxy | SEC | Y 2021 | ||||||
| Aerovate Therapeutics, Inc. (JBIO) | 3/30/2022 5:07:33 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $175,363,000 | EPS -$1.87 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 3/30/2022 4:48:11 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $175,363,000 | EPS -$0.07 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/15/2021 8:15:25 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $184,125,000 | EPS -$0.26 | ||
| Aerovate Therapeutics, Inc. (JBIO) | 11/15/2021 8:02:25 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $184,125,000 | EPS -$0.26 | Export Earnings Model | ||
| Aerovate Therapeutics, Inc. (JBIO) | 8/16/2021 8:11:41 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $62,434,000 | |||
| Aerovate Therapeutics, Inc. (JBIO) | 8/16/2021 8:06:03 AM | View | Earnings | SEC | 2Q 2021 | Assets $62,434,000 |